In March 1999, a 35 yr. old female patient presented with a palpable mass in the left breast and positive axillary lymph nodes. Invasive ductal carcinoma (IDC) was diagnosed after core cut biopsy. Receptors were negative and a skin probe was free of malignant infiltration. Preoperative chemotherapy (PCT) was given and because of complete remission breast-conserving therapy performed in May. The specimen showed a small residual tumor of IDC only. Under continued PCT a local relapse appeared on the same side within one month postoperatively. A triple therapy consisting of PCT, Radiofrequency-Hyperthermia (RF-HT) and Radiotherapy (RTX) was given when by end of August 1999 the area of the local malignant inflammation has exceeded 100 cm2. The recurrent disease completely disappeared. RF-HT in combination with PCT and RTX seems to be an excellent tool in patients with recurrent breast cancer.
INTRODUCTION
Manifest recurrent disease in breast cancer can effectively be controlled in only about 50% of patients. Despite the recent positive reports 1 , RF-HT is controversially discussed in the therapy concept of recurrent breast cancer. This is due to the absence of standardized methods of describing the temporally and spatially variant temperature distribution observed during RF-HT. Because of its tremendous progression under running chemotherapy this special case has demanded all out efforts available and had to be treated outside of every available protocol.
MATERIAL AND METHOD
In March 1999, a 35 yr. old female patient presented with a palpable mass of 3 x 3 x 3 cm in the lateral quadrants of the left breast, palpation of axillary and supra-claviculary lymph nodes was positive ( Figure1). Standardized photodocumentation -front torso, left breast frontal and oblique 45°-is seen as a standard of quality assessment and was performed before each treatment onset.
Open skin and core cut biopsy were performed. Histopathology of the frozen and permanent section showed an invasive low differentiated ductal carcinoma combined with intraductal carcinoma (pTxL1G3). Estrogen and Progesterone receptor were negative. The skin probes did not reveal any malignant infiltration or lymphangiosis carcinomatosa. The chest wall and lymphatics (axilla, parasternal and ipsilateral supraclavicular lymph nodes) were irradiated with photon fields (6 MV) up to a total dose of 56 Gray (Gy), 2 Gy daily, 5 days a week. The parasternal region received 30 Gy with photons followed by an electron field (9 meV) with 26 Gy in 2 Gy fractions.
RESULT
An impressive response as shown above could be observed and the recurrent disease completely disappeared (Figure 2 ).
But within one month after triple modality treatment has ended, this aggressive form of breast cancer unfortunately progressed outside of the radiation and HT fields. Finally the patient died in spring 2000. 
CONCLUSION
The literature 2 , 3 is mostly inconsistent and there are published only small uncontrolled trials using triple therapy 4 , 5 , 6 . Unfortunately they do not demonstrate to be effective because of the complexity and heterogenity of the patients being studied. On the other side the heterogenity of the devices used to produce hyperthermia and the lack of standardized methods to measure a thermal dose are also hindering to prove the effectiveness of hyperthermia. As early as in 1992 Bornstein and co-workers 7 used a triple modality in patients with locally or regionally recurrent or advanced breast cancer. They could observe an overall complete response rate of 53%. One has not to forget that for patients with a recurrent tumor who are mostly excellent informed about their current status, the "cosmetic nonappearance" of a recurrent disease may be more important than the idea of being healed. And as in our case -despite the rapid progression after therapy-it could be shown that RF-HT in combination with PCT and RTX seems to be an excellent opportunity in patients with recurrent breast cancer.
